Drug Resistance in Tuberculosis-Reference-Cited by-同舟云学术

Drug Resistance in Tuberculosis

Published:1990-06 Issue:3 Volume:2 Page:147-151
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Al-Orainey I.O.M.¹

Affiliation:

1. Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.1990.11739007

Reference24 articles.

1. Medical Research Council. Treatment of pulmonary tuberculosis with streptomycin and para-aminosalicylic acid. Br Med J 1950; 2: 1073–1085.

2. Pyle M: Relative numbers of resistant tubercle bacilli in sputa of patients before and during treatment with streptomycin. Proc Mayo Clin 1947; 22: 465–473.

3. Lederberg J, Lederberg E M: Replica plating and indirect selection of bacterial mutants. J Bacteriol 1952; 63: 399–406.

4. David HL: Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appi Microbiol 1970; 28: 810–814.

5. David HL. Drug resistance in M. tuberculosis and other mycobacteria. Clin Chest Med 1980; 1: 227–230.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melaleuca armillaris Essential Oil in Combination With Rifaximin Against Staphylococcus aureus Isolated of Dairy Cows;Frontiers in Veterinary Science;2020-07-15

2. Unsuccessful antituberculosis medication treatment: A characteristic summarization in a suburban province with dense communities of Myanmar migrant worker in Bangkok Metropolitan Region, Thailand;Biomedical and Biotechnology Research Journal (BBRJ);2019

3. Drug-resistant tuberculosis and cross-border patient: A retrospective analysis from a Thailand–Myanmar border area;Biomedical and Biotechnology Research Journal (BBRJ);2019

4. A Bayesian nonparametric model for spatially distributed multivariate binary data with application to a multidrug-resistant tuberculosis (MDR-TB) study;Biometrics;2014-06-27

5. Rifaximin: New Therapeutic Indication and Future Directions;Clinical Therapeutics;2011-07